Clinical Trials Browser

Phase 1 × Breast Neoplasms × DCC-2036 × Clear all

NCT02824575 2022-04-04

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Phase 1 Terminated

Breast Neoplasms, Neoplasm Metastasis